A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection - Paper

Yue Ruan, Robert E J Ryder, Parijat De, Benjamin C T Field, Parth Narendran, Ahmed Iqbal, Rajiv Gandhi, Sophie Harris, Dinesh Nagi, Umaira Aziz, Efthimia Karra, Sandip Ghosh, Wasim Hanif, Amy E Edwards, Mansoor Zafar, Umesh Dashora, Kinga A Várnai, Jim Davies, Sarah H Wild, Emma G Wilmot, David Webb, Kamlesh Khunti, Rustam Rea, ABCD Covid-19 audit group

Discipline:

Diabetes

Clinical taxonomy:

COVID-19

Inpatient care

Type 1 diabetes mellitus

Resource taxonomy:

Audit

Privacy Policy | Website Terms and Conditions

Address for correspondence: ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602 Email: info@abcd.care

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd

ABCD Corporate Pharma Sponsors; Gold: Astra Zeneca, Lilly, Sanofi. Silver: A.Menarini Farmaceutica Internazionale SRL,

ABCD Corporate Pump & Device Supporters, Gold: Abbott Laboratories Ltd, Dexcom, GlucoRx, Insulet International Ltd, Ypsomed Ltd; Silver: Air Liquide Healthcare Ltd, Medtrum Ltd, Menarini Diagnostics; Bronze: Roche Diabetes Care.

Read the ABCD statement on pharmaceutical industry funding

Search form

You are here

A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection - Paper

ABCD Webinar Series